Results 91 to 100 of about 265 (112)

Zilebesiran – nový princíp a nová nádej v liečbe hypertenzie / Zilebesiran – a new principle and new hope in the treatment of hypertension

Cardiology Letters
exaly   +2 more sources

Zilebesiran as an Innovative Treatment for Arterial Hypertension

Public Health of the Far East- Peer-reviewed scientific and practical journal
Hypertension is an extremely common noncommunicable disease, affecting an estimated 1.3 billion adults (aged 30–79 years) worldwide, and its prevalence has doubled over the past 20 years [1]. Many patients fail to achieve guideline-recommended blood pressure targets. New technologies are currently being actively developed to achieve these goals.
G. I. Bosy, A.S. Vlasova, M.A. Gumerova, N. A. Fedosova, N. S. Shnyakin, N. A. Surikova   +5 more
openaire   +1 more source

Zilebesiran, a ribonucleic acid interference agent targeting angiotensinogen, proves a promising approach in hypertension

Cardiovascular Research
David John Webb
exaly   +3 more sources

CONSISTENT ANTIHYPERTENSIVE EFFICACY OF THE RNA INTERFERENCE THERAPEUTIC ZILEBESIRAN: SUBGROUP RESULTS FROM THE KARDIA-1 PHASE 2 STUDY IN PATIENTS WITH HYPERTENSION

Journal of the American College of Cardiology
SAXENA, M, Desai, AS, Azizi, M, Gupta, A, Lee, J, Goyal, N, Guo, W, Makarova, N, Stiglitz, D, Bakris, GL, Zappe, D   +10 more
exaly   +2 more sources

Zilebesiran for Hypertension. Reply.

The New England journal of medicine, 2023
Akshay S, Desai, Marianne T, Sweetser, George L, Bakris   +2 more
openaire   +1 more source

[Gene therapy for hypertension: focus on zilebesiran].

Giornale italiano di cardiologia (2006), 2023
Fabio, Angeli, Martina, Zappa, Claudia, Bartolini, Paolo, Verdecchia   +3 more
openaire   +1 more source

Hypertension Cure Research Progress: The Use of Zilebesiran in Hypertension

Journal of Medical and Clinical Studies, 2023
openaire   +1 more source

Faculty Opinions recommendation of Zilebesiran, an RNA interference therapeutic agent for hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2023
openaire   +1 more source

Zilebesiran: A Potential Life-Altering Remedy for Hypertensive Patients

Cardiology
openaire   +2 more sources

Zilebesiran

openaire   +1 more source